1. Aurinia Pharmaceuticals (AUPH) Appoints Dr. Daniel Billen to Board

    Aurinia Pharmaceuticals (AUPH) Appoints Dr. Daniel Billen to Board

    Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced it has appointed Dr. Daniel Billen to its Board of Directors. Dr. Billen’s appointment is effective April 29, 2019 concurrent with the previously announced appointment of Mr. Peter Greenleaf as Chief Executive Officer and elevation of Dr. George Milne to Chairman of the Board...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned